Patent · US Expired

Preventives/remedies for thickened scar, keloid or chronic arthritic diseases

US7300916B2 · kind B2 · utility

6Cited by
2References
4Claims
0Family size

Assignee

Inventors

Key dates

Filing dateFeb 26, 2002
Grant dateNov 27, 2007
Priority date
Expiry dateDec 13, 2022

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61K2039/505
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

A pharmaceutical preparation for preventing and/or treating hypertrophic scars, keloid or chronic arthritic diseases comprising as an effective component an erythropoietin antagonist. More specifically, there is provided a pharmaceutical preparation for preventing and/or treating hypertrophic scars, keloid or chronic arthritic diseases comprising as an effective component an erythropoietin antagonist such as an anti-erythropoietin antibody, an erythropoietin receptor protein, etc. This pharmaceutical preparation has excellent prophylactic and/or therapeutic effects on collagenous hyperproliferation such as hypertrophic scars, keloid, etc., or chronic arthritic diseases such as rheumatoid arthritis, etc.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.